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Abstract
Background: Vaginal breech delivery is associated with adverse perinatal outcome. The aim of this study was to
identify factors associated with adverse perinatal outcome in term breech pregnancies, and to provide clinicians
an aid in selecting women for a trial of vaginal labor with the fetus in breech position.
Methods: We conducted a retrospective, nationwide, Finnish population-based case-control study. All planned
singleton vaginal deliveries at term with the fetus in breech position between the years 2005 and 2014 were
analyzed. The study’s end point was a composite set of adverse perinatal outcomes. All infants with an adverse
outcome were compared to the infants with normal outcomes. A multivariate logistic regression model was used
to analyze the data.
Results: An adverse perinatal outcome was recorded for 73 (1.5%) infants. According to the study results fetal
growth restriction (adjusted odds ratio, 2.94; 95% CI, 1.30–6.67), oligohydramnios (adjusted odds ratio, 2.94; 95% CI,
1.15–7.18), a history of cesarean section (adjusted odds ratio, 2.94; 95% CI, 1.28–6.77, gestational diabetes (adjusted
odds ratio, 2.89; 95% CI, 1.54–5.40), epidural anesthesia (adjusted odds ratio, 2.20; 95% CI, 1.29–3.75) and nulliparity
(adjusted odds ratio, 1.84; 95% CI, 1.10–3.08) were associated with adverse perinatal outcome.
Conclusions: Adverse perinatal outcome in planned vaginal breech labor at term is associated with fetal growth
restriction, oligohydramnios, previous cesarean delivery, gestational diabetes, nulliparity and epidural anesthesia.
Keywords: Breech presentation, Risk factors, Cesarean section, Oligohydramnios, Fetal growth restriction, Gestational
diabetes, Perinatal morbidity, Perinatal mortality, Macrosomia
Background
Breech presentation at term occurs in two to three per
cent of all singleton term deliveries [1, 2]. The majority
of breech pregnancies are delivered nowadays by
cesarean section [3], as planned vaginal breech delivery
is controversial. Some studies and most importantly the
term breech trial by Hannah M. have reported that
planned vaginal breech labor is associated with adverse
perinatal outcome [4, 5]. Other studies have been
published which show that vaginal breech delivery is safe
for mother and child if the women for a trial of labor
are carefully selected and labor management takes place
in an appropriate obstetric setting [6, 7]. Many national
associations of obstetricians and gynecologists have
defined guidelines to determine under which circum-
stances a vaginal breech delivery is feasible [8–10], but
even under these circumstances adverse perinatal
outcomes still occur [11]. In recent literature there are
only two articles that review risk factors associated with
adverse perinatal outcome in planned vaginal breech
delivery, but neither article had the statistical power to
analyze risk factors for perinatal mortality and severe
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neonatal outcome [11, 12]. More evidence and a better
understanding of factors associated with adverse peri-
natal outcome might aid in making optimal selections
for a trial of vaginal breech labor. The aim of this study
is to determine risk factors for adverse perinatal out-
come in planned vaginal breech delivery, to aid practi-
tioners in the selection of women for vaginal breech
delivery and to limit the risks of adverse perinatal
outcome.
Methods
The study was population-based, and the studied popu-
lation included all deliveries from January 1, 2005 to
December 31, 2014. It included all deliveries that had a
trial of vaginal labor at term with a singleton fetus in
breech presentation (frank, complete and incomplete
breech presentation). The following pregnancies and in-
fants were excluded from the study: Multiple gestations,
preterm pregnancies, antepartum diagnosed stillbirths,
placenta previa and infants with congenital malforma-
tions. Primary outcome was a composite index of
perinatal and neonatal morbidity and mortality. Compar-
isons were made between all infants with adverse out-
come and all infants with normal outcome. The flow
chart of the selection process is shown in Fig. 1. Adverse
perinatal outcome was defined as umbilical arterial pH
< 7.00, five minute Apgar score below four and/or neo-
natal mortality during the first six days of life.
The study utilized the data of the national medical
birth register and the hospital discharge register, main-
tained by the National Institute for Health and Welfare.
Data for the medical birth register is collected at all ma-
ternity hospitals in Finland. Reporting to the national
registers is obligatory, thus the data is valid and gives
good, nationwide coverage [13]. The medical birth regis-
ter includes all live births and stillbirths with a birth
weight of 500 g or more or with a gestational age of
22 weeks or more. The hospital discharge register con-
tains information on all inpatient periods in all Finnish
hospitals and all outpatient visits recorded in the public
sector. The registered information includes demographic
data, maternal information before and after the delivery,
intrapartum procedures and complications, as well as
neonatal outcome. The information is coded according
to the International Statistical Classification of Diseases
and Related Health Problems 10th Revision (ICD-10).
Maternal factors, pregnancy factors and neonatal/fetal
characteristics were studied. Maternal factors included
parity, maternal age, smoking, bodymass index (BMI)
before pregnancy, previous cesarean section as well as
diabetes mellitus type one and two. Factors regarding
the pregnancy were gestational age at delivery, gesta-
tional diabetes [defined as an abnormal two-hour oral
glucose tolerance test, the test is diagnostic if one
glucose level is elevated (Fasting glucose ≥ 5.3 mmol/L,
or one hour ≥ 10.0 mmol/L, or two hour ≥ 8.5 mmol/L)],
preeclampsia [defined as new onset of hypertension
(≥140/90 mmHg) and proteinuria or hypertension and
end-organ dysfunction with or without proteinuria after
20 weeks of gestation in a previously normotensive
woman], assisted reproduction technology, oligohydram-
nios (defined as amniotic fluid index below 5 cm), epi-
dural anesthesia and post term pregnancies. Neonatal
and fetal characteristics included neonatal sex (male), birth
weight, macrosomia defined as birth weight above 4500 g,
fetal growth restriction defined as birth weight < 2SD. Stat-
istical differences in categorical variables were evaluated
with the chi-square test and differences in continuous vari-
ables by the Mann-Whitney U test as appropriate.
Fig. 1 The data flow in the current study
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Differences were deemed to be significant if p <0.05. In
addition, 95% confidence intervals (CI) were calculated.
The estimated risks (odd ratios (ORs) with their 95% CIs]
of adverse outcomes were calculated using binary logistic
regression. A multiple regression model was used for the
adjusting. The data was analyzed using SPSS for Windows
V.19.0, Chicago, Illinois, USA. The reporting of this study
conforms to the STROBE statement. Authorization to
use the data was obtained from the National Institute
for Health and Welfare as required by national data
protection legislation in Finland (Reference number
THL/1200/5.05.00/2012).
Results
During the study period of ten years 10 057 women
went into labor with the fetus in breech presentation.
This results in a breech presentation rate of 2% in
singleton pregnancies at term, excluding pregnancies
with congenital malformations. Out of these women
4805 women had a trial of vaginal breech labor, of
which 3123 (65%) had a vaginal delivery and 1682
(35%) women had their delivery converted to a
cesarean section.
Seventythree (1.5%) neonates had a severe adverse
perinatal outcome (Table 1). The multivariable analysis
showed that mothers of infants with adverse perinatal
outcome were more often nulliparous (adjusted odds ra-
tio [aOR], 1.84; 95% CI, 1.10–3.08), they had more often
gestational diabetes (aOR, 2.89; 95% CI, 1.54–5.40), a
history of cesarean section (aOR, 2.94; 95% CI, 1.28–
6.77), they were more often diagnosed with oligohy-
dramnios (aOR, 2.94; 95% CI, 1.15–7.18) and had more
often epidural anesthesia (aOR, 2.20; 95% CI, 1.29–3.75).
Among the neonatal factors fetal growth restriction
(aOR, 2.94; 95% CI, 1.30–6.67) was significantly associ-
ated with an increased risk of adverse perinatal out-
come. We identified four cases of uterus rupture in the
study population, all of which had a history of cesarean
section. Out of these four cases one neonate had an
adverse perinatal outcome; three did not suffer from
adverse outcome (odds ratio [OR], 21.89; 95% CI,
2.25–213.01) (Table 2).
Maternal age, a BMI over 30, maternal smoking, aver-
age gestational age at delivery, diabetes mellitus type I
an II, preeclampsia, neonatal weight, neonatal sex, birth
weight, assisted reproduction technology, macrosomia
and post term pregnancies were not associated with
adverse perinatal outcome (Table 2).
Discussion
Planned vaginal breech delivery at term is associated
with adverse perinatal short-term outcome. The main
findings of this study showed that nulliparity, gestational
diabetes, fetal growth restriction, a history of cesarean
section, oligohydramnios and epidural anesthesia were
associated with adverse perinatal outcome in vaginal
breech deliveries at term. Secondly, the frequency of se-
vere perinatal outcome was with 1.6% (73 out of 4805
cases) much lower than in the term breech trail with
5.1% [4]. These results can be explained with a violation
of the stringent criteria for vaginal breech delivery in the
term breech trial, as in one third of all cases analyzed in
the term breech trial the fetal sizes were considered
small (<3000 g at term). Of all stillbirths and perinatal
deaths notified in the term breech trial 69% (11 of 16
cases) were too small for their gestational age [4]. We
identified fetal growth restriction (< −2SD /IUGR) also
as a main risk factor for severe adverse perinatal out-
come in this study. This result is coherent with a sec-
ondary analysis of the term breech trial data by Su,
which showed that birth weight <2800 g was associated
with adverse perinatal outcome [14]. Fetal growth
restriction is a known risk factor for adverse fetal out-
comes including stillbirth, cerebral palsy, neonatal death,
and hypoxia ischemic encephalopathy [15–18]. Due to
these risks many guidelines for vaginal breech delivery
state fetal growth restrictions as a contraindication for a
trial of vaginal labor [8–10].
We showed that adverse perinatal outcome was also
associated with oligohydramnios. Oligohydramnios is as-
sociated with adverse pregnancy outcomes [19]. These
adverse perinatal outcomes are most likely caused by
umbilical cord compression, uteroplacental insufficiency
and meconium aspiration [19]. Oligohydramnios is asso-
ciated with reduced fetal movements [20], which is
linked to adverse perinatal outcome [21–23].
The analysis showed that nulliparity was associated
with adverse outcome in vaginal breech delivery. Other
authors have already before shown that infants born to
primigravid women have a higher rate of perinatal
morbidity [24]. We found that the rate of women with
gestational diabetes was also significantly higher in preg-
nancies with adverse perinatal outcome in vaginal
breech delivery. Gestational diabetes has been associated
with adverse perinatal outcomes before, in pregnancies
with the fetus in cephalic presentation, as it increases
Table 1 Adverse perinatal outcome in planned vaginal breech
delivery
Perinatal outcome Planned vaginal delivery N = 4805
N (%)
Early neonatal mortality < 7 da 5 (0.1)
Umbilical arterial pH < 7.00a 42 (0.9)
Five min Apgar score < 4a 30 (0.6)
Combined adverse perinatal
outcomeb
73 (1.5)
aCriteria included in combined adverse perinatal outcome
bInfants with one or more factors
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perinatal mortality, the risk for macrosomia and pre-
eclampsia [25]. A history of cesarean section was identi-
fied as a risk factor for adverse perinatal outcome. If the
first cesarean section was due to dystocia, women have a
higher risk to undergo another pathologic delivery [26].
It is also known that a trial of vaginal labor after
cesarean section is associated with a higher perinatal
mortality, birth asphyxia and sepsis [26]. The adverse
outcome is mainly caused by uterine rupture and a pro-
longed labor [26, 27]. Our data confirms that a history
of cesarean section is related to a higher risk of uterus
rupture and that uterus rupture is associated with
adverse perinatal outcome.
This study showed that women who received epidural
anesthesia had a 2.2 times higher risk of adverse peri-
natal outcome. Earlier studies have shown that epidural
anesthesia in connection with breech delivery is associ-
ated with a longer duration of labor and an increased
need for augmentation of labor with oxytocin infusion
[28]. It is not possible to tell whether the association be-
tween epidural anesthesia and adverse outcome is due to
the epidural prolonging labor and delaying expulsion of
the fetus or whether epidural anesthesia is simply used
more in prolonged labors that inherently have a higher
risk of expulsive delay and adverse outcome [11]. Inter-
estingly macrosomia was not identified as a risk factor
for adverse perinatal outcome in vaginal breech labors at
term. However, macrosomia is associated with adverse
perinatal outcome in cephalic presentation [29]. Dystocia
related to macrosomia is a major concern in vaginal
breech delivery at term and this concern is reflected in
many guidelines. The guidelines of the Royal College of
Obstetricians and Gynaecologists and the German
guidelines suggest that fetuses in breech presentation
with an estimated weight ≥ 3800 g should not be de-
livered vaginally [8, 10]. The Canadian guidelines
suggest that fetuses ≥ 4000 g should not be delivered
vaginally [9].
The main strength of this study is that it has the statis-
tical power to generalize data regarding the outcomes of
the infants. Another advantage of this study is that it is
up to the author’s knowledge the largest population-
based, case-control study reviewing risk factors in
vaginal breech delivery at term. The study is based on
nationwide data in a country, in which the medical treat-
ment of pregnancies is very homogenous, as there are
no private hospitals dealing with pregnancies. The study
is limited by its retrospective design and due to a lack of
Table 2 Factors associated with adverse perinatal outcome in planned vaginal breech delivery
All vaginal deliveries and emergency breech
cesarean sections at term (2005–2014)
Adverse outcomea N = 73 Normal outcome N = 4732
N/mean %/SD N/mean %/SD P value OR 95% CI aOR 95% CI
Nulliparous
Maternal age in years mean + SD 30.3 5.0 30.1 5.1 0.740
BMI≥ 30 9 10.7 233 7.7 0.303 1.45 (0.71–2.92)
Smoking 16 19.0 421 13.9 0.176 1.46 (0.84–2.55)
Diabetes mellitus type I 1 1.2 6 0.2 0.058 6.09 (0.73–51.16)
Diabetes mellitus type II 0 6 0.2
Preeclampsia 2 2.4 74 2.4 0.975 0.98 (0.24–4.05)
Gestational age at delivery mean + SD 39.7 1.1 39.6 1.2 0.433
Gestational diabetes 14 6.7 197 6.5 <0.001 2.89 (1.60–5.21) 2.89 (1.54–5.40)b
Fetal growth restrictionc 7 8.3 87 2.9 0.004 3.09 (1.38–6.88) 2.94 (1.30–6.67)b
Assisted reproduction technology 3 3.6 50 1.6 0.178 2.21 (0.68–7.25)
History of cesarean section 8 9.5 139 4.6 0.035 2.20 (1.04–4.64) 2.94 (1.28–6.77)b
Oligohydramnios 5 6.0 57 1.9 0.008 3.31 (1.29–8.49) 2.94 (1.15–7.81)b
Epidural anesthesia 65 77.4 1739 57.2 <0.001 2.56 (1.53–4.29) 2.20 (1.29–3.75)b
Post term pregnancies > 40 10 11.9 418 13.8 0.627 0.85 (0.43–165)
Birth weight in grams 3293 431 3341 416 0.311
Neonatal sex (male) 37 44.0 1367 45.0 0.865 0.96 (0.62–14.49)
Uterus rupture 1 1.4 3 0.1 <0.001 21.89 (2.25–213.01) NAd
Macrosomia (birth weight >4500 g) 4 5.5 428 9.0 0.291 0.58 (0.21–1.61)
aEarly neonatal mortality <7d, umbilical arterial pH < 7.00, 5 min Apgar score < 4
bAdjusted for nulliparous; gestational diabetes; fetal growth restriction (<−2SD); history of cesarean section; oligohydramnios; epidural anesthesia
cFetal growth restriction defined as birth weight < 2SD
dNA Not available
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information regarding whether the studied women had a
history of breech presentation in previous pregnancies
and a lack of information regarding the reason for previ-
ous cesarean sections. Additionally the studied variables
were restricted to databank availability. The Finnish
birth register lacked for example records of neonatal
cord arterial base deficit. Infants in breech position born
vaginally often suffer from significant respiratory acidosis
due to cord compression from which they easily recover
by ventilation. It would be important to differentiate these
cases from cases with significant metabolic acidosis, as
metabolic acidosis is probably the best early indicator for
a higher risk of adverse neurodevelopmental outcome.
Unfortunately, this data was not available and therefore
such an analysis was beyond the scope of the present
study and warrants attention in future studies.
Conclusions
The study confirmed fetal growth restriction as a risk
factor for adverse perinatal outcome. Oligohydramnios,
nulliparity, gestational diabetes, epidural anesthesia and
a history of cesarean section were identified as new risk
factors for adverse perinatal outcome in a trial of labor
in pregnancies with the fetus in breech position. These
factors should be taken into account when counseling
women and included in all national guidelines for vagi-
nal breech delivery. In particular, vaginal delivery with
the fetus in breech presentation should be avoided when
fetal growth is restricted. Macrosomia as an individual
risk factor for adverse perinatal outcome should be
reviewed; further studies are needed to investigate this
issue. A more careful selection of the women eligible for
vaginal breech delivery has the potential to reduce the
risk of adverse perinatal outcome. Caution and a willing-
ness to abandon a trial of labor if circumstances are not
favorable are essential for the safety of mother and child.
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